AnalystBookAnalystBook
Product
AnalystBookOne product — the whole research loop

What's inside

Company IntelligenceUnderstand any company in hoursFiling IntelligenceNever miss what changedAna — AI AnalystCited answers, zero guessingResearch BriefsThe analysis, already writtenResearch MemoryYour research compounds
Research
Research LibraryBriefs written from the filingsLook up a companyEvery covered company's intelligence pageBlogFindings from the record
Who it's for
Individual investorsEquity analysts & PMsFamily offices & small fundsCredit analystsJournalists & forensic researchers
Pricing
Company
TechnologyAboutSecurityContact
Sign inStart free trial
Menu

Product

AnalystBook — the whole productCompany IntelligenceFiling IntelligenceAna — AI AnalystResearch BriefsResearch Memory

Research

Research LibraryLook up a companyBlog

Who it's for

Individual investorsEquity analysts & PMsFamily offices & small fundsCredit analystsJournalists & forensic researchers

More

PricingTechnologyAboutSecurityContact

AnalystBook Research · Company Intelligence

Replimune Group, Inc.

REPLNasdaq

Built from Replimune Group, Inc.'s own SEC filings · updates as new filings land · every figure links to its source

or browse all covered companies

← Research Library

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score -0.42 — distress zone — historically elevated failure riskWatch

Leadership changes

From Replimune Group, Inc.'s own filings, the day they're filed.

  • Pamela Esposito · chief business officer · departureeff. 2024-05-31
  • Tanya Lewis · current chief development operations officer · departureeff. 2024-05-31
  • Sushil Patel · chief executive officer · appointmenteff. 2024-04-01

Latest filings

  • 8-K · Company announcement2026-05-29
  • 8-K · Company announcement2026-04-13
  • 8-K · Company announcement2026-02-03
  • 10-Q · Quarterly report2026-02-03
  • 8-K · Company announcement2026-01-12
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, every figure source-linked🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask anything about Replimune Group, Inc., every answer cited🔒
  • The Intelligence Brief — added when Replimune Group, Inc.'s brief passes our SEC-figure check🔒

Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.

See the full REPL record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.

AnalystBook

For research purposes. Not investment advice.

Product

The whole productCompany IntelligenceFiling IntelligenceAna — AI AnalystResearch BriefsResearch MemoryResearch LibraryPricing

Who it's for

Individual investorsEquity analysts & PMsFamily offices & small fundsCredit analystsJournalists & forensic researchers

Compare

How AnalystBook compares

Company

TechnologyAboutSecurityContactBlogSign in

Legal

Terms of ServicePrivacy PolicyRefund Policy